Animal Studies
Exploring hepatopulmonary syndrome is challenging due to its rarity, often leading researchers to rely on animal studies for insights. In particular, studies involving rats with liver cirrhosis induced by bile duct ligation have proven valuable in understanding the condition. This experimental approach produces symptoms resembling hepatopulmonary syndrome, allowing researchers to uncover novel molecules that shed light on its development. The identification of these molecules holds promise for the future, as they may serve as potential targets for the treatment of hepatopulmonary syndrome.
Understanding the Severity of Hepatopulmonary Syndrome
The severity of hepatopulmonary syndrome can be categorized into four degrees, namely mild, moderate, severe, and very severe, depending on the level of hypoxemia, which is the deficiency of oxygen in the blood. Studies conducted on patients with hepatopulmonary syndrome have indicated that the majority of cases fall within the mild to moderate range. Earlier research had initially reported a higher prevalence of severe and very severe cases; however, this discrepancy was attributed to inadequate screening criteria.
Regardless of the degree of severity, individuals diagnosed with hepatopulmonary syndrome experience a significantly diminished quality of life due to difficulties in breathing and inadequate oxygen supply during sleep.